The company behind blood pressure medication tablets has expanded a recall for two products after trace amounts of a possible cancer-causing ingredient was detected in the tablets. Torrent Pharmaceuticals Limited said its Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, are affected by the recall. The company said the recall only affects products found to have more than the FDA-allowable amount of NMBA. The fourth recall includes an additional 36 lots of Losartan Potassium Tablets USP and 68 lots of Losartan Potassium/hydrochlorothiazide Tablets, USP. The medication is used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy and nephropathy in Type 2 diabetic patients.

Source: Fox News April 19, 2019 15:33 UTC